Please login to the form below

Cello Health appoints health economics and market access expert in the United States

Yardley, PA June 6, 2016 - Today, Cello Health, a global provider of marketing advisory services to the pharmaceutical and health sectors, announced the appointment of Yi Han, PhD, MBA, as Executive Vice President of Market Access and HEOR in the US.  

Han has 15 years of experience in leadership positions in both biotechnology and pharmaceutical companies, such as IPSEN Biopharmaceuticals, Hoffmann-La Roche, and GlaxoSmithKline, and also in service firms.  Prior to joining Cello Health, Han was a Senior Vice President at Grey Health Group and led the market access consultancy WG Consulting.   
Han specializes in health economics, market access strategy, and data mining.  He also has extensive experience in launching and life cycle management of pharmaceutical products, vaccines, and medical devices in US and global markets.  He has made significant contributions to help clients establish pricing and contracting strategy at the product or portfolio level to secure optimal revenue growth.  

Julia Ralston, CEO of Cello Health, US, commented, “Yi brings us the perfect blend of technical and commercial expertise in HEOR data generation and also market access strategy and consulting.  He will lead the growth of our market access and HEOR services, leveraging the pre-existing HEOR and market access skills across our communications, consulting, and market research capabilities to drive our rapid expansion in this area that is so essential to our clients’ commercial success.”  

Han will be based at Cello Health’s Yardley, PA office, where the existing Cello Health Communications business unit has a legacy service offering in the dissemination of HEOR data.  Cello Health has offices in Boston, New York City, Philadelphia, Chicago, San Francisco, and London.

About Cello Health: Cello Health delivers cutting-edge professional marketing services to the global pharmaceutical and health sectors. Cello Health consists of three distinct capabilities to deliver a fusion of expertise to unlock the potential of organizations, brands and assets:
  • Cello Health Insight: global marketing research and customer insight
  • Cello Health Consulting: strategic consultancy
  • Cello Health Communications: evidence and engagement

6th June 2016


Company Details

Cello Health

+44 (0)20 7812 8460

Contact Website

11-13 Charterhouse Buildings

Latest content on this profile

Cello Health Launches New Social Insight & Analytics Business
Cello Health Logic offers pharmaceutical companies the ability to make sense of healthcare social media conversations and deliver actionable insights.
Cello Health
Managing value: Why early asset development and commercialization is important
Realising the full value of your asset – clinically and commercially – means thinking beyond the pure scientific value, even at the very early stages of development.
Cello Health
Optimising market research data in rare disease
Helping to provide powerful insights into the burden of disease and the patient-caregiver experience.
Cello Health
Cello Health Communications Accelerates its Digital Offering with New Leadership Appointments
Rick Lang and Craig Lipski join the organization in senior digital roles
Cello Health
Duncan Munro joins Cello Health Insight as Joint Head of ‘IQ’ Practice
Supporting quantitative team’s continued growth, bringing specialist advanced analytics, methodological and technical expertise.
Cello Health
Maria Eletskaya joins Cello Health Insight
Bolstering senior team for expanding 'IQ' Quantitative practice
Cello Health